EV/EBITDA
11.76
-0.23-1.92%
Fri, 21 Feb 2025 21:20:00 GMT
Summary
- As of February 23, 2025, SUPN EV/EBITDA is 11.76, with a fall of -0.23 (-1.92%) during the most recent trading day.
- Over the past year, SUPN EV/EBITDA has dropped by -5.01 (-29.87%).
- SUPN EV/EBITDA is now -86.19% below its all-time high of 85.14.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.9% | -1.9% | -1.9% |
1 m1 month | -14.3% | -14.3% | -14.3% |
3 m3 months | -7.7% | -7.7% | -7.7% |
6 m6 months | -24.2% | -3.6% | -4.7% |
ytdytd | -8.6% | -8.6% | -8.6% |
1 y1 year | -29.9% | +21.3% | +17.2% |
5 y5 years | +42.7% | +25.7% | +37.8% |
SUPN EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -17.7% | 11.76 | at low | |
3 m | 3-month | 14.29 | -17.7% | 11.76 | at low |
6 m | 6-month | 15.73 | -25.2% | 10.95 | +7.4% |
1 y | 1-year | 23.48 | -49.9% | 10.95 | +7.4% |
3 y | 3-year | 23.48 | -49.9% | 9.53 | +23.4% |
5 y | 5-year | 23.48 | -49.9% | 5.41 | +117.4% |
alltime | all time | 85.14 | -86.2% | -144.43 | +108.1% |
Supernus Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | 11.76(-8.6%) |
2024 | 12.86(-25.3%) |
2023 | 17.21(+15.4%) |
2022 | 14.91(+8.4%) |
2021 | 13.75(+99.3%) |
2020 | 6.90(-15.4%) |
2019 | 8.16(-28.0%) |
Date | Value |
---|---|
2018 | 11.34(-35.7%) |
2017 | 17.63(-15.0%) |
2016 | 20.73(-33.4%) |
2015 | 31.14(-133.7%) |
2014 | -92.53(+2456.1%) |
2013 | -3.62(-25.1%) |
2012 | -4.83 |
FAQ
- What is Supernus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SUPN is 11.76
What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high EV/EBITDA is 85.14
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals EV/EBITDA has changed by -1.10 (-8.55%) since the beginning of the year
What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by -5.01 (-29.87%)